2,049
Views
10
CrossRef citations to date
0
Altmetric
Articles

Prevention of ischemia-reperfusion lung injury during static cold preservation by supplementation of standard preservation solution with HEMO2life® in pig lung transplantation model

, , , , , & show all
Pages 1773-1780 | Received 31 Jul 2017, Accepted 11 Oct 2017, Published online: 25 Oct 2017

References

  • ISHLT: The International Society for Heart & Lung Transplantation [Internet]; 2017. [cited 2017 Jun 6]. Available from: https://www.ishlt.org/registries/slides.asp?slides=heartLungRegistry
  • Christie JD, Carby M, Bag R, et al. Report of the ISHLT working group on primary lung graft dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2005;24:1454–1459.
  • Lee JC, Christie JD. Primary graft dysfunction. Clin Chest Med. 2011;32:279–293.
  • Ailawadi G, Lau CL, Smith PW, et al. Does reperfusion injury still cause significant mortality after lung transplantation? J Thorac Cardiovasc Surg. 2009;137:688–694.
  • Kreisel D, Krupnick AS, Puri V, et al. Short- and long-term outcomes of 1000 adult lung transplant recipients at a single center. J Thorac Cardiovasc Surg. 2011;141:215–222.
  • Whitson BA, Prekker ME, Herrington CS, et al. Primary graft dysfunction and long-term pulmonary function after lung transplantation. J Heart Lung Transplant. 2007;26:1004–1011.
  • Daud SA, Yusen RD, Meyers BF, et al. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med. 2007;175:507–513.
  • Fiser SM, Tribble CG, Long SM, et al. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg. 2002;73:1041–1048.
  • Kosieradzki M, Rowiński W. Ischemia/reperfusion injury in kidney transplantation: mechanisms and prevention. Transplant Proc. 2008;40:3279–3288.
  • de Perrot M, Liu M, Waddell TK, et al. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med. 2003;167:490–511.
  • Salahudeen AK. Cold ischemic injury of transplanted kidneys: new insights from experimental studies. Am J Physiol Renal Physiol. 2004;287:F181–F187.
  • Jayle C, Favreau F, Zhang K, et al. Comparison of protective effects of trimetazidine against experimental warm ischemia of different durations: early and long-term effects in a pig kidney model. Am J Physiol Renal Physiol. 2007;292:F1082–F1093.
  • Thuillier R, Dutheil D, Trieu MTN, et al. Supplementation With a new therapeutic oxygen carrier reduces chronic fibrosis and organ dysfunction in kidney static preservation: a new O2 therapeutic molecule improves static kidney preservation. Am J Transplant. 2011;11:1845–1860.
  • Mallet V, Dutheil D, Polard V, et al. Dose-ranging study of the performance of the natural oxygen transporter HEMO2life® in organ preservation. Artif Organs. 2014;38:691–701.
  • Rousselot M, Delpy E, Drieu La Rochelle CL, et al. Arenicola marina extracellular hemoglobin: a new promising blood substitute. Biotechnol J. 2006;1:333–345.
  • Rousselot M, Le Guen D, Chabasse C, et al. Novel dissociation mechanism of a polychaetous annelid extracellular haemoglobin. FEBS J. 2006;273:1582–1596.
  • Zal F, Green BN, Lallier FH, et al. Quaternary structure of the extracellular haemoglobin of the lugworm Arenicola marina: a multi-angle-laser-light-scattering and electrospray-ionisation-mass-spectrometry analysis. Eur J Biochem. 1997;243:85–92.
  • Lama VN, Belperio JA, Christie JD, et al. Models of lung transplant research: a consensus statement from the National Heart, Lung, and Blood Institute workshop. JCI Insight. 2017;2(9):93121.
  • Trebbia G, Sage E, Fadel E, et al. Ex vivo assessment of extravascular lung water with transpumonary thermodilution. J Heart Lung Transplant. 2013;32:840–842.
  • Pizanis N, Petrov A, Heckmann J, et al. A new preservation solution for lung transplantation: evaluation in a porcine transplantation model. J Heart Lung Transplant. 2012;31:310–317.
  • Belzer FO, Southard JH. Principles of solid-organ preservation by cold storage. Transplantation. 1988;45:673–676.
  • Hosgood SA, Nicholson HFL, Nicholson ML. Oxygenated kidney preservation techniques. Transplantation. 2012;93:455–459.
  • Favreau F, Thuillier R, Cau J, et al. Anti-thrombin therapy during warm ischemia and cold preservation prevents chronic kidney graft fibrosis in a DCD model. Am J Transplant off J Am Soc Transplant Am Soc Transpl Surg. 2010;10:30–39.
  • Kumar S, Allen DA, Kieswich JE, et al. Dexamethasone ameliorates renal ischemia-reperfusion injury. J Am Soc Nephrol JASN. 2009;20:2412–2425.
  • Maathuis M-HJ, Leuvenink HGD, Ploeg RJ. Perspectives in organ preservation. Transplantation. 2007;83:1289–1298.
  • Matsumoto S, Kuroda Y. Perfluorocarbon for organ preservation before transplantation. Transplantation. 2002;74:1804–1809.
  • Kuroda Y, Kawamura T, Suzuki Y, et al. A new, simple method for cold storage of the pancreas using perfluorochemical. Transplantation. 1988;46:457–460.
  • Kakehata J, Yamaguchi T, Togashi H, et al. Therapeutic potentials of an artificial oxygen-carrier, liposome-encapsulated hemoglobin, for ischemia/reperfusion-induced cerebral dysfunction in rats. J Pharmacol Sci. 2010;114:189–197.
  • Spahn DR, Kocian R. Artificial O2 carriers: status in 2005. Curr Pharm Des. 2005;11:4099–4114.
  • Regner KR, Nilakantan V, Ryan RP, et al. Protective effect of Lifor solution in experimental renal ischemia-reperfusion injury. J Surg Res. 2010;164:e291–e297.
  • Farrar D, Grocott M. Intravenous artificial oxygen carriers. Hosp Med. 2003;64:352–356.
  • Tsai AG, Intaglietta M, Sakai H, et al. Microcirculation and NO-CO studies of a natural extracellular hemoglobin developed for an oxygen therapeutic carrier. Curr Drug Discov Technol. 2012;9:166–172.
  • Fukuse T, Hirata T, Ishikawa S, et al. Optimal alveolar oxygen concentration for cold storage of the lung. Transplantation. 2001;72:300–304.
  • Bacha EA, Hervé P, Murakami S, et al. Lasting beneficial effect of short-term inhaled nitric oxide on graft function after lung transplantation. Paris-Sud University Lung Transplantation Group. J Thorac Cardiovasc Surg. 1996;112:590–598.
  • Sommer S, Warnecke G, Hohlfeld J, et al. Pulmonary preservation with LPD and celsior solution in porcine lung transplantation after 24 h of cold ischemia. Eur J Cardiothorac Surg. 2004;l26:151–157.
  • Inci I, Erne B, Arni S, et al. Prevention of primary graft dysfunction in lung transplantation by N-acetylcysteine after prolonged cold ischemia. J Heart Lung Transplant off Publ Int Soc Heart Transplant. 2010;29:1293–1301.
  • LaPar DJ, Laubach VE, Emaminia A, et al. Pretreatment strategy with adenosine A2A receptor agonist attenuates reperfusion injury in a preclinical porcine lung transplantation model. J Thorac Cardiovasc Surg. 2011;142:887–894.
  • Shaver CM, Ware LB. Primary graft dysfunction: pathophysiology to guide new preventive therapies. Expert Rev Respir Med. 2017;11:119–128.
  • Laubach VE, Sharma AK. Mechanisms of lung ischemia-reperfusion injury. Curr Opin Organ Transplant. 2016;21:246–252.
  • Yu AY, Frid MG, Shimoda LA, et al. Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung. Am J Physiol. 1998;275:L818–L826.
  • Carter YM, Gelman AE, Kreisel D. Pathogenesis, management, and consequences of primary graft dysfunction. Semin Thorac Cardiovasc Surg. 2008;20:165–172.
  • Fiser SM, Tribble CG, Long SM, et al. Lung transplant reperfusion injury involves pulmonary macrophages and circulating leukocytes in a biphasic response. J Thorac Cardiovasc Surg. 2001;121:1069–1075.
  • Guo WA, Knight PR, Raghavendran K. The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome. Intensive Care Med. 2012;38:1588–1598.
  • Chan JK, Roth J, Oppenheim JJ, et al. Alarmins: awaiting a clinical response. J Clin Invest. 2012;122:2711–2719.
  • Abraham E, Arcaroli J, Carmody A, et al. HMG-1 as a mediator of acute lung inflammation. J Immunol. 2000;165:2950–2954.
  • Gallinat A, Paul A, Efferz P, et al. Hypothermic reconditioning of porcine kidney grafts by short-term preimplantation machine perfusion. Transplantation. 2012;93:787–793.
  • Goto T, Ishizaka A, Kobayashi F, et al. Importance of tumor necrosis factor-alpha cleavage process in post-transplantation lung injury in rats. Am J Respir Crit Care Med. 2004;170:1239–1246.
  • Saito T, Liu M, Binnie M, et al. Distinct expression patterns of alveolar “ alarmins” in subtypes of chronic lung allograft dysfunction”. Am J Transplant. 2014;14:1425–1432.
  • Todd JL, Palmer SM. Bronchiolitis obliterans syndrome: the final frontier for lung transplantation. Chest. 2011;140:502–508.
  • Verleden SE, Vandermeulen E, Ruttens D, et al. Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS). Semin Respir Crit Care Med. 2013;34:352–360.
  • Li G, Liang X, Lotze MT. HMGB1: the central cytokine for all lymphoid cells. Front Immunol. 2013;4:68.
  • Nakagiri T, Inoue M, Morii E, et al. Local IL-17 production and a decrease in peripheral blood regulatory T Cells in an animal model of bronchiolitis obliterans. Transplantation. 2010;89:1312–1319.
  • Sato M, Waddell TK, Wagnetz U, et al. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. J Heart Lung Transplant. 2011;30:735–742.
  • Sato M, Hwang DM, Waddell TK, et al. Progression pattern of restrictive allograft syndrome after lung transplantation. J Heart Lung Transplant. 2013;32:23–30.
  • Ueno H, Matsuda T, Hashimoto S, et al. Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med. 2004;170:1310–1316.
  • Sharma AK, LaPar DJ, Zhao Y, et al. Natural killer T cell-derived IL-17 mediates lung ischemia-reperfusion injury. Am J Respir Crit Care Med. 2011;183:1539–1549.
  • Sharma AK, LaPar DJ, Stone ML, Z, et al. Receptor for advanced glycation end products (RAGE) on iNKT cells mediates lung ischemia-reperfusion injury: RAGE and NKT Cells inlung reperfusion injury. Am J Transplant. 2013;13:2255–2267.
  • Hamilton BCS, Kukreja J, Ware LB, et al. Protein biomarkers associated with primary graft dysfunction following lung transplantation. Am J Physiol Lung Cell Mol Physiol. 2017;312:L531–L541.
  • Moreno I, Vicente R, Ramos F, et al. Determination of Interleukin-6 in lung transplantation: association with primary graft dysfunction. Transplant Proc. 2007;39:2425–2426.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.